Fig. 2.
Percentages of failure in drug development and commercialization of drugs. Efficacy is a major cause of withdrawal from clinical trials. Drug repositioning may provide increased efficacy with comparatively low failure rates.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.